Shutterstock photo
Markets

Baron Asset Fund Comments on West Pharmaceutical Services

Shares of West Pharmaceutical Services, Inc. ( NYSE:WST ) , a manufacturer of packaging components and delivery devices for injectable drugs, gained after reporting impressive quarterly financial results. Management provided solid guidance for 2017 and reaffirmed its goals for strong growth through 2020. We continue to believe that West can double its earnings over the next five years, driven by sales of higher margin packaging components and proprietary products to the pharmaceutical and biotechnology industries.

From Barron Asset Fund fourth quarter 2016 commentary .

Premium Members

This article first appeared on GuruFocus .

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.


The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

In This Story

WST

Other Topics

Stocks

Latest Markets Videos